Effect of a single neonatal oxytocin treatment (hormonal imprinting) on the biogenic amine level of the adult rat brain: Could oxytocin-induced labor cause pervasive developmental diseases?

Reproductive Sciences

Volumn 20, Issue 10, 2013, Pages 1255-1263

  Hashemi, F ^a   Tekes, Kornélia ^a   Laufer, R ^a   Szegi, P ^a   Tothfalusi L ^a   Csaba, G ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

autism; hormonal imprinting; neonatal treatments; oxytocin; parturition

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHOL; ADRENALIN; BIOGENIC AMINE; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN; OXYTOCIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; FEMALE; HYPOTHALAMUS; LABOR INDUCTION; MALE; MEDULLA OBLONGATA; METABOLITE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM;

AUTISM; HORMONAL IMPRINTING; NEONATAL TREATMENTS; OXYTOCIN; PARTURITION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BIOGENIC AMINES; BRAIN; BRAIN CHEMISTRY; DEVELOPMENTAL DISABILITIES; FEMALE; LABOR, INDUCED; MALE; OXYTOCIN; PREGNANCY; RATS; RATS, WISTAR;

EID: 84872837527     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113483010     Document Type: Article

References (52)

1. Csaba G. Phylogeny and ontogeny of hormone receptors: the selection theory of receptor formation and hormonal imprinting. Biol Rev. 1980 ; 55 (1). 47-63
2. Csaba G. Hormonal imprinting: its role in the evolution and development of hormones and receptors. Cell Biol Int. 2000 ; 24 (7). 407-414
3. Tchernitchin A, Tchernitchin N. Imprinting of heterodifferentation by prenatal or perinatal exposure to hormones, pharmaceuticals, pollutants and other agents and conditions. Med Sci Res. 1992 ; 20: 391-397
4. Csaba G.. Hormonal imprinting: phylogeny, ontogeny, diseases and possible role in present-day human evolution. Cell Biochem Funct. 2008 ; 26 (1). 1-10
5. Csaba G.. The present state in the phylogeny and ontogeny of hormone receptors. Horm Metab Res. 1984 ; 16 (7). 329-335
6. Csaba G, Inczefi-Gonda Á, Dobozy O. Hereditary transmission to the F1 generation of hormonal imprinting (receptor memory) induced in rats by neonatal exposure to insulin. Acta Physiol Hung. 1984 ; 63 (2). 93-99
7. Csaba G, Nagy SU. Influence of the neonatal suppression of TSH production (neonatal hyperthyroidism) on response to TSH in adulthood. J Endocrinol Invest. 1985 ; 8 (6). 557-559
8. Csaba G. The biological basis and clinical significance of hormonal imprinting, an epigenetic process. Clin Epigenet. 2011 ; 2 (2). 187-196
9. Csaba G, Tekes K. Is the brain hormonally imprintable?. Brain Dev. 2005 ; 27 (7). 465-471
10. Csaba G, Knippel B, Karabélyos C, Inczefi-Gonda Á, Hantos M, Tekes K. Impact of single neonatal serotonin treatment (hormonal imprinting) on the brain serotonin content and sexual behavior of adult rats. Life Sci. 2003 ; 73 (21). 2703-2711
11. Csaba G, Knippel B, Karabélyos C, et al. Effect of neonatal beta-endorphin imprinting on sexual behavior and brain serotonin level in adult rats. Life Sci. 2003 ; 73 (1). 103-114
12. Tekes K, Gyenge M, Sótonyi P, Csaba G. Effect of neonatal nociceptin or nocistatin imprinting on the brain concentration of biogenic amines and their metabolites. Brain Dev. 2009 ; 31 (4). 282-287
13. Tekes K, Gyenge M, Folyovich A, Csaba G. Influence of neonatal vitamin A or vitamin D treatment on the concentration of biogenic amines and their metabolites in the adult rat brain. Horm Metab Res. 2009 ; 41 (4). 277-280
14. Tekes K, Gyenge M, Hantos M, Csaba G.. Transgenerational hormonal imprinting caused by vitamin A or vitamin D treatment of newborn rats. Alterations in the biogenic amine content of the adult brain. Brain Dev. 2009 ; 31 (9). 666-670
15. Tekes K, Szegi P, Laufer R, Hantos M, Csaba G. Effect of perinatal stress on the biogenic amine neurotransmitter level of the adult rat's brain. Int J Dev Neurisci. 2011 ; 29 (2). 171-175
16. Tekes K, Gyenge M, Hantos M, Csaba G. Effect of beta-endorphin imprinting during late pregnancy on the brain serotonin and plasma nocistatin levels of adult male rats. Horm Metab Res. 2007 ; 39 (7). 479-481
17. Csaba G, Knippel B, Karabélyos C, Inczefi-Gonda Á, Hantos M, Tekes K. Endorphin excess at weaning durably influences sexual activity, uterine estrogen receptor binding capacity and brain serotonin level of female rats. Horm Metab Res. 2004 ; 36 (1). 39-43
18. Plothe C.. The perinatal application of oxytocin and its potential influence on the human psyche. Prenatal Perinatal Psychol Med. :
19. Carter CS. Developmental consequences of oxytocin. Physiol Behav. 2003 ; 79 (3). 383-397
20. Kramer KM, Cushing BS, Carter CS. Developmental effects of oxytocin on stress response: single versus repeated exposure. Physiol Behav. 2003 ; 79 (4-5). 775-782
21. Modi ME, Young LJ. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies. Horm Behav. 2012 ; 61 (3). 340-350
22. Bales KL, Abdelnabi M, Cushing BS, Ottinger MA, Carter CS. Effects of neonatal oxytocin manipulations on male reproductive potential in prairie voles. Physiol Behav. 2004 ; 81 (3). 519-526
23. Bales KL, van Westerhuyzen JA, Lewis-Reese AD, Grotte ND, Lanter JA, Carter CS. Oxytocin has dose-dependent developmental effects on pair-bonding and alloparental care in female prairie voles. Horm Behav. 2007 ; 52 (2). 274-279
24. Bales KL, Carter CS. Developmental exposure to oxytocin facilitates partner preferences in male prairie voles (Microtus ochrogaster). Behav Neurosci. 2003 ; 117 (4). 854-859
25. Eaton JL, Roache L, Nguyen KN, et al. Organizational effects of oxytocin on serotonin innervation. Dev Psychobiol. 2012 ; 54 (1). 92-97
26. Wallace Lj, Traeger JS.. DOPAC distribution and regulation in striatal dopaminergic varicosities and extracellular space. Synapse. 2012 ; 66 (2). 160-173
27. Revin SB, John SA. Simultaneous determination of two important dopamine metabolites at physiological pH by voltammetry. Anal Methods. 2012 ; 4 (2). 348-352
28. Hornykiewicz O. Brain monoamines and parkinsonism. Natl Inst Drug Abuse Res Monogr Ser. 1975 ; 3: 13-21
29. Sandyk R, Iacono RP, Bamford CR. The hypothalamus in Parkinson disease. Ital J Neurol Sci. 1987 ; 8 (3). 227-234
30. Muthian G, Mackey V, King J, Charlton CG. Modelling a senzitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Neuroscience. 2010 ; 169 (3). 1085-1093
31. Wyatt RJ, Karoum F, Casanova MF. Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia. Biol Psychiatry. 1995 ; 38 (1). 4-12
32. Sharma RP, Javaid JL, Davis JM, Janicak PG. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence and inpatient drug-free period. Biol Psychiatry. 1998 ; 44 (6). 488-492
33. Stanley B, Molcho A, Stanley M, et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry. 2000 ; 157 (4). 609-614
34. Mehlman PT, Higley JD, Faucher I, et al. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. Am J Psychiatry. 1994 ; 151 (10). 1485-1491
35. Baskerville TA, Douglas AJ. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci Ther. 2010 ; 16 (3). e92 - e123
36. Skuse DH, Gallagher L. Dopaminergic-neuropeptide interactions in the social brain. Trends Cogn Sci. 2009 ; 13 (1). 27-35
37. Green JJ, Hollander E. Autism and oxytocin: new developments in transitional approaches to therapeutics. Neurotherapeutics. 2010 ; 7 (3). 250-257
38. Lee HJ, Macbeth AH, Pagani JH, Young WS. Oxytocin: the great facilitator of life. Prog Neurobiol. 2009 ; 88 (2). 127-151
39. Harony H, Wagner S. The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder. Neurosignals. 2010 ; 18 (2). 82-97
40. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure and chemistry. Biol Psychiatry. 2007 ; 62 (8). 847-855
41. Carter CS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders. Behav Brain Res. 2007 ; 176 (1). 170-186
42. Cheslack-Postava K, Jordan-Young HM. Autism spectrum disorder: toward a gendered embodiment model. Soc Sci Med. 2011 ; 74 (11). 1667-1774
43. Moleti CA. Trends and controversies in labor induction. MCN Am J Matern Child Nurs. 2009 ; 34 (1). 40-47
44. Mackenzie IZ. Induction of labour at the start of the new millenium. Reproduction. 2006 ; 131 (6). 989-998
45. Newschaffer CJ, Croen LA, Daniels J, et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007 ; 28: 235-258
46. Keyes KM, Susser E, Cheslak-Postava K, Fountain C, Liu K, Bearman PS. Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. Int J Epidemiol. 2011 ; 41 (2). 495-503
47. Pinborough-Zimmerman J, Bilder D, Satterfield R, Hossain S, McMahon W. The impact of surveillance method and record source on autism prevalence: collaboration with Utah Maternal and Child Health programs. Matern Child Health J. 2010 ; 14 (3). 392-400
48. Wahl RU. Could oxytocin administration during labor contribute to autism and related behavioral disorders? - A look at the literature. Med Hypotheses. 2004 ; 63 (3). 456-460
49. Csaba G.. Thoughts on the cultural evolution of man. Developmental imprinting and transgenerational effect. Riv Biol. 2007 ; 100 (3). 461-474
50. Angelidou A, Asadi S, Alysandratos KD, Karagkouni A, Kourembanas S, Theoharides TC. Perinatal stress, brain inflammation and risk of autism - review and proposal. BMC Pediatr. 2012 ; 12: 89
51. Kosaka H, Munesue T, Ishitobi M, et al. Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry. 2012 ; 12: 110
52. Matsuzaki M, Matsushita H, Tomizawa K, Matsui H. Oxytocin: a therapeutic target for mental disorders. J Physiol Sci. 2012 ; 62 (6). 441-444